India Says Inferior Drug Ingredients From China Hard to Swallow
India’s drug authority has accused several Chinese pharmaceutical suppliers of providing poor-quality raw ingredients, and may blacklist them, news agency IANS reported Sunday.
New Delhi issued notices to eight Chinese drugmakers after a special inspection team of the Drug Controller General of India (DCGI) found that the companies were supplying substandard ingredients to the south Asian country.
- 1Update: China Demands Answers for Swedish Police’s ‘Brutal’ Treatment of Tourists
- 2China Could Ban Exports of Products Crucial to U.S. Manufacturers, Former Finance Minister Says
- 3 State-Owned Firms to Build $6.5 Billion Petrochemical Refinery in Alberta
- 4Trump Slaps New Tariffs on $200 Billion of Chinese Goods
- 5Merck Slashes Key Cancer Drug Price for China
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas